| Original language | English (US) |
|---|---|
| Pages (from-to) | 1102-1103 |
| Number of pages | 2 |
| Journal | Neurology |
| Volume | 77 |
| Issue number | 11 |
| DOIs | |
| State | Published - Sep 13 2011 |
ASJC Scopus subject areas
- Clinical Neurology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Neurology, Vol. 77, No. 11, 13.09.2011, p. 1102-1103.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Novel p.Ile151Val mutation in VCP in A patient of african american descent with sporadic ALS
AU - DeJesus-Hernandez, M.
AU - Desaro, P.
AU - Johnston, A.
AU - Ross, O. A.
AU - Wszolek, Z. K.
AU - Ertekin-Taner, N.
AU - Graff-Radford, N. R.
AU - Rademakers, R.
AU - Boylan, K.
N1 - Funding Information: Study funding: Supported by NIH grants R01 AG26251 (R.R.), R01 NS065782 (R.R.), P50NS072187 (Z.K.W.), P50 AG016574 (N.E.-T., R.R., N.R.G.-R.), KL2 RR024151 (N.E.-T.), R01 032990 (N.E.-T.) , the ALS Association (R.R.), and the Mayo Clinic Florida ALS Center Donor Funds and Mayo Foundation. Funding Information: Disclosure: M. DeJesus-Hernandez, O. Desaro, and A. Johnston report no disclosures. Dr. Ross serves on the editorial boards of Open Longevity Science and PLoS ONE and receives research support from the NIH, the Michael J. Fox Foundation, and the American Heart Association. Dr. Wszolek serves as Co-Editor-in-Chief of Parkinsonism and Related Disorders, Regional Editor of the European Journal of Neurology, and on the editorial boards of Neurologia i Neurochirurgia Polska, Advances in Rehabilitation, the Medical Journal of the Rzeszow University, and Clinical and Experimental Medical Letters; holds and has contractual rights for receipt of future royalty payments from patents re: A novel polynucleotide involved in heritable Parkinson's disease; receives royalties from publishing Parkinsonism and Related Disorders (Elsevier, 2007, 2008, 2009) and the European Journal of Neurology (Wiley-Blackwell, 2007, 2008, 2009); and receives research support from Allergan, Inc., the NIH, the Pacific Alzheimer Research Foundation (Canada), the CIHR, the Mayo Clinic Florida Research Committee CR program, and a gift from Carl Edward Bolch, Jr., and Susan Bass Bolch. Dr. Ertekin-Taner receives research support from the NIH and the Siragusa Foundation. Dr. Graff-Radford serves on a scientific advisory board for Codman; serves on the editorial boards of The Neurologist and Alzheimer Disease and Therapy; has received publishing royalties from UpToDate, Inc.; and receives research support from Pfizer Inc, Janssen, Forest Laboratories, Inc., Medivation, Inc., Allon Therapeutics, Inc., and the NIH/NIA. Dr. Rademakers holds patents re: Methods and materials for detecting and treating dementia and receives research support from the NIH, the Pacific Alzheimer Research Foundation (Canada), the Association for Frontotemporal Dementia, the Amyotrophic Lateral Sclerosis Association, CurePSP, and the Consortium for Frontotemporal Dementia. Dr. Boylan receives/has received research support from Cytokinetics, Inc., Synapse Biomedical, Inc., Avanir Pharmaceuticals, Mayo Foundation, the NIH/NINDS, and the ALS Association.
PY - 2011/9/13
Y1 - 2011/9/13
UR - http://www.scopus.com/inward/record.url?scp=80155141546&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80155141546&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e31822e563c
DO - 10.1212/WNL.0b013e31822e563c
M3 - Article
C2 - 21880997
AN - SCOPUS:80155141546
SN - 0028-3878
VL - 77
SP - 1102
EP - 1103
JO - Neurology
JF - Neurology
IS - 11
ER -